{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:40:15Z","timestamp":1761975615438},"reference-count":199,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Epigenomics"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.2217\/epi-2016-0166","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T10:09:00Z","timestamp":1493892540000},"page":"737-755","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":17,"title":["Epigenetics in endometrial carcinogenesis \u2013 part 1: DNA methylation"],"prefix":"10.1080","volume":"9","author":[{"given":"Carla","family":"Bartosch","sequence":"first","affiliation":[{"name":"Department of Pathology, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal"},{"name":"Cancer Biology &amp; Epigenetics Group, Research Center (CI-IPOP), Portuguese Oncology Institute of Porto, Porto, Portugal"},{"name":"Department of Pathology &amp; Oncology, Medical Faculty, University of Porto, Porto, Portugal"},{"name":"Porto Comprehensive Cancer Center (P.ccc), Porto, Portugal"}]},{"given":"Jos\u00e9 Manuel","family":"Lopes","sequence":"additional","affiliation":[{"name":"Department of Pathology &amp; Oncology, Medical Faculty, University of Porto, Porto, Portugal"},{"name":"Department of Pathology, Centro Hospitalar S\u00e3o Jo\u00e3o (CHSJ), Porto, Portugal"},{"name":"IPATIMUP \u2013 Institute of Molecular Pathology &amp; Immunology, University of Porto, Porto, Portugal"},{"name":"I3S \u2013 Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, Porto, Portugal"}]},{"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[{"name":"Cancer Biology &amp; Epigenetics Group, Research Center (CI-IPOP), Portuguese Oncology Institute of Porto, Porto, Portugal"},{"name":"Porto Comprehensive Cancer Center (P.ccc), Porto, Portugal"},{"name":"Department of Pathology &amp; Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal"}]}],"member":"301","published-online":{"date-parts":[[2017,5,4]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(83)90111-7"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/his.12053"},{"issue":"2","key":"e_1_3_2_5_1","first-page":"33","article-title":"The genomics and genetics of endometrial cancer","volume":"2012","author":"O\u2019hara AJ","year":"2012","unstructured":"O\u2019hara AJ , BellDW . The genomics and genetics of endometrial cancer . Adv. Genomics Genet.2012 ( 2 ), 33 \u2013 47 ( 2012 ).","journal-title":"Adv. Genomics Genet."},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00130-0"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.289.5485.1751"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2004.07.007"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.10.032"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2012.09.007"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2007.00897.x"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.01.049"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29106"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.08.041"},{"issue":"5","key":"e_1_3_2_15_1","first-page":"977","article-title":"Analysis of candidate target genes for mononucleotide repeat mutation in microsatellite instability-high (MSI-H) endometrial cancer","volume":"35","author":"Kawaguchi M","year":"2009","unstructured":"Kawaguchi M , BannoK , YanokuraMet al. Analysis of candidate target genes for mononucleotide repeat mutation in microsatellite instability-high (MSI-H) endometrial cancer . Int. J. Oncol.35 ( 5 ), 977 \u2013 982 ( 2009 ).","journal-title":"Int. J. Oncol."},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/11.4.445"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205924"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/his.12581"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000111"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12113"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2012.02.008"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature14465"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3230"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2013.08.001"},{"key":"e_1_3_2_25_1","volume-title":"Epigenetic Biomarkers and Diagnostics.","author":"Garc\u00eda-Gim\u00e9nez JL","year":"2016","unstructured":"Garc\u00eda-Gim\u00e9nez JL . Epigenetic Biomarkers and Diagnostics.Academic Press ( 2016 )."},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2014.04.008"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1101\/gr.197194.115"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm4043"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.2217\/epi.14.80"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature14192"},{"key":"e_1_3_2_31_1","first-page":"67","volume-title":"The Molecular Basis of Cancer.","author":"Baylin SB","year":"2014","unstructured":"Baylin SB . Epigenetics and cancer . In : The Molecular Basis of Cancer.MendelsohnJ , HowleyPM , IsraelMA , GrayJW , ThompsonCB ( Eds ). Elsevier Health Sciences , PA, USA , 67 \u2013 78 ( 2014 )."},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-004-1059-4"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1210\/me.2013-1340"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.09.030"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.01.031"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep015"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1507"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206365"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-3394"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1781"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.22"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.2217\/epi.15.21"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-6685-1_15"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-43624-1_15"},{"issue":"11","key":"e_1_3_2_45_1","first-page":"824","article-title":"Is global DNA methylation in sporadic uterine adenocarcinomas in women a result of histological and clinical tumor advancement?","volume":"80","author":"Postawski K","year":"2009","unstructured":"Postawski K , Galecka-JosseM , BaranowskiW . Is global DNA methylation in sporadic uterine adenocarcinomas in women a result of histological and clinical tumor advancement?Ginekol. Pol.80 ( 11 ), 824 \u2013 827 ( 2009 ).","journal-title":"Ginekol. Pol."},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-868"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1999.5662"},{"issue":"10","key":"e_1_3_2_48_1","first-page":"4026","article-title":"Loss of estrogen receptor (ER) expression in endometrial tumors is not associated with de novo methylation of the 5\u2019 end of the ER gene","volume":"6","author":"Navari JR","year":"2000","unstructured":"Navari JR , RolandPY , KehPet al. Loss of estrogen receptor (ER) expression in endometrial tumors is not associated with de novo methylation of the 5\u2019 end of the ER gene . Clin. Cancer Res.6 ( 10 ), 4026 \u2013 4032 ( 2000 ).","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"e_1_3_2_49_1","first-page":"3262","article-title":"Cytosine-phosphoguanine methylation of estrogen receptors in endometrial cancer","volume":"61","author":"Sasaki M","year":"2001","unstructured":"Sasaki M , KotcherguinaL , DhariaA , FujimotoS , DahiyaR . Cytosine-phosphoguanine methylation of estrogen receptors in endometrial cancer . Cancer Res.61 ( 8 ), 3262 \u2013 3266 ( 2001 ).","journal-title":"Cancer Res."},{"issue":"1","key":"e_1_3_2_50_1","first-page":"139","article-title":"Down-regulation of estrogen receptor by the methylation of the estrogen receptor gene in endometrial carcinoma","volume":"22","author":"Shiozawa T","year":"2002","unstructured":"Shiozawa T , ItohK , HoriuchiA , KonishiI , FujiiS , NikaidoT . Down-regulation of estrogen receptor by the methylation of the estrogen receptor gene in endometrial carcinoma . Anticancer Res.22 ( 1A ), 139 \u2013 143 ( 2002 ).","journal-title":"Anticancer Res."},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2002.124720"},{"issue":"1","key":"e_1_3_2_52_1","first-page":"97","article-title":"Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer","volume":"61","author":"Sasaki M","year":"2001","unstructured":"Sasaki M , DhariaA , OhBR , TanakaY , FujimotoS , DahiyaR . Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer . Cancer Res.61 ( 1 ), 97 \u2013 102 ( 2001 ).","journal-title":"Cancer Res."},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.05.035"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2392"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134969"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1159\/000324496"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1177\/107155760301000110"},{"issue":"3","key":"e_1_3_2_58_1","first-page":"881","article-title":"Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors","volume":"62","author":"Dai D","year":"2002","unstructured":"Dai D , WolfDM , LitmanES , WhiteMJ , LeslieKK . Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors . Cancer Res.62 ( 3 ), 881 \u2013 886 ( 2002 ).","journal-title":"Cancer Res."},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.01.042"},{"issue":"9","key":"e_1_3_2_60_1","first-page":"1860","article-title":"Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action","volume":"58","author":"Kumar NS","year":"1998","unstructured":"Kumar NS , RicherJ , OwenG , LitmanE , HorwitzKB , LeslieKK . Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action . Cancer Res.58 ( 9 ), 1860 \u2013 1865 ( 1998 ).","journal-title":"Cancer Res."},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.14.12.8356-8364.1994"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2007.02.002"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068907"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.4161\/epi.5.6.12431"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.4161\/epi.6.7.16315"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0021"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmu060"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62674-4"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.4161\/epi.24506"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.3109\/07420528.2012.719967"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-692"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12956"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/65.1.46"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(02)00408-1"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq724"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26455"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40495-015-0028-8"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.23937\/2378-3419\/2\/1\/1013"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0700"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.12.6870"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-009-9204-1"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-012-9478-0"},{"issue":"6","key":"e_1_3_2_83_1","first-page":"2277","article-title":"Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma","volume":"9","author":"Whitcomb BP","year":"2003","unstructured":"Whitcomb BP , MutchDG , HerzogTJ , RaderJS , GibbRK , GoodfellowPJ . Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma . Clin. Cancer Res.9 ( 6 ), 2277 \u2013 2287 ( 2003 ).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/8.4.661"},{"issue":"9","key":"e_1_3_2_85_1","first-page":"3607","article-title":"Methylation of hMLH1 in a population-based series of endometrial carcinomas","volume":"6","author":"Salvesen HB","year":"2000","unstructured":"Salvesen HB , MacdonaldN , RyanAet al. Methylation of hMLH1 in a population-based series of endometrial carcinomas . Clin. Cancer Res.6 ( 9 ), 3607 \u2013 3613 ( 2000 ).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65492-2"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000415"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2002.6724"},{"issue":"3","key":"e_1_3_2_89_1","first-page":"267","article-title":"Aberrant DNA hypermethylation of hMLH-1 and CDKN2A\/p16 genes in benign, premalignant and malignant endometrial lesions","volume":"30","author":"Guida M","year":"2009","unstructured":"Guida M , SanguedolceF , BufoPet al. Aberrant DNA hypermethylation of hMLH-1 and CDKN2A\/p16 genes in benign, premalignant and malignant endometrial lesions . Eur. J. Gynaecol. Oncol.30 ( 3 ), 267 \u2013 270 ( 2009 ).","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.05.020"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202178"},{"issue":"3","key":"e_1_3_2_92_1","first-page":"535","article-title":"Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability","volume":"17","author":"Kondo E","year":"2000","unstructured":"Kondo E , FurukawaT , YoshinagaKet al. Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability . Int. J. Oncol.17 ( 3 ), 535 \u2013 541 ( 2000 ).","journal-title":"Int. J. Oncol."},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.2107"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-212"},{"issue":"6","key":"e_1_3_2_95_1","first-page":"1189","article-title":"Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer","volume":"16","author":"Banno K","year":"2006","unstructured":"Banno K , YanokuraM , SusumuNet al. Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer . Oncol. Rep.16 ( 6 ), 1189 \u2013 1196 ( 2006 ).","journal-title":"Oncol. Rep."},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4609"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-10-0014"},{"issue":"5","key":"e_1_3_2_98_1","first-page":"957","article-title":"Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series","volume":"14","author":"Macdonald ND","year":"2004","unstructured":"Macdonald ND , SalvesenHB , RyanAet al. Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series . Int. J. Gynecol. Cancer14 ( 5 ), 957 \u2013 965 ( 2004 ).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2679"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.263"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.08.038"},{"issue":"4","key":"e_1_3_2_102_1","first-page":"793","article-title":"Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia","volume":"59","author":"Esteller M","year":"1999","unstructured":"Esteller M , HamiltonSR , BurgerPC , BaylinSB , HermanJG . Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia . Cancer Res.59 ( 4 ), 793 \u2013 797 ( 1999 ).","journal-title":"Cancer Res."},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/gem009"},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.15430\/JCP.2013.18.4.351"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.06.028"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20010101)91:1<22::AID-IJC1002>3.0.CO;2-S"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2006.05.007"},{"issue":"6","key":"e_1_3_2_108_1","first-page":"1615","article-title":"Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression","volume":"25","author":"Salvesen HB","year":"2004","unstructured":"Salvesen HB , StefanssonI , KretzschmarEIet al. Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression . Int. J. Oncol.25 ( 6 ), 1615 \u2013 1623 ( 2004 ).","journal-title":"Int. J. Oncol."},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64902-4"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23494"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2008.38"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2007.01172.x"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.3727\/000000006783981125"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21991"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21609"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl455"},{"key":"e_1_3_2_117_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2013.2752"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2008.03147.x"},{"key":"e_1_3_2_119_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0506"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-6645"},{"issue":"7","key":"e_1_3_2_121_1","first-page":"675","article-title":"Hypermethylation of selected genes in endometrial carcinogenesis","volume":"34","author":"Visnovsky J","year":"2013","unstructured":"Visnovsky J , FiolkaR , KudelaEet al. Hypermethylation of selected genes in endometrial carcinogenesis . Neuro Endocrinol. Lett.34 ( 7 ), 675 \u2013 680 ( 2013 ).","journal-title":"Neuro Endocrinol. Lett."},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2010.08.001"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2668"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2009.01397.x"},{"issue":"5","key":"e_1_3_2_125_1","first-page":"947","article-title":"APC, beta-catenin, and E-cadherin and the development of recurrent endometrial carcinoma","volume":"14","author":"Pijnenborg JM","year":"2004","unstructured":"Pijnenborg JM , KistersN , Van EngelandMet al. APC, beta-catenin, and E-cadherin and the development of recurrent endometrial carcinoma . Int. J. Gynecol. Cancer14 ( 5 ), 947 \u2013 956 ( 2004 ).","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"13","key":"e_1_3_2_126_1","first-page":"3663","article-title":"Methylation of adenomatous polyposis coli in endometrial cancer occurs more frequently in tumors with microsatellite instability phenotype","volume":"62","author":"Zysman M","year":"2002","unstructured":"Zysman M , SakaA , MillarA , KnightJ , ChapmanW , BapatB . Methylation of adenomatous polyposis coli in endometrial cancer occurs more frequently in tumors with microsatellite instability phenotype . Cancer Res.62 ( 13 ), 3663 \u2013 3666 ( 2002 ).","journal-title":"Cancer Res."},{"key":"e_1_3_2_127_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgg121"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11157"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.3109\/07357907.2010.512603"},{"key":"e_1_3_2_130_1","doi-asserted-by":"publisher","DOI":"10.1159\/000333077"},{"key":"e_1_3_2_131_1","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2008.19.4.241"},{"key":"e_1_3_2_132_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1310"},{"key":"e_1_3_2_133_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0850"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.12.5.15963"},{"key":"e_1_3_2_135_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-0427"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.11.017"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.5507\/bp.2013.035"},{"issue":"1","key":"e_1_3_2_138_1","first-page":"153","article-title":"Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis","volume":"6","author":"Salvesen HB","year":"2000","unstructured":"Salvesen HB , DasS , AkslenLA . Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis . Clin. Cancer Res.6 ( 1 ), 153 \u2013 159 ( 2000 ).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_139_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20702"},{"issue":"2","key":"e_1_3_2_140_1","first-page":"851","article-title":"Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients","volume":"26","author":"Yanokura M","year":"2006","unstructured":"Yanokura M , BannoK , SusumuNet al. Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients . Anticancer Res.26 ( 2A ), 851 \u2013 856 ( 2006 ).","journal-title":"Anticancer Res."},{"key":"e_1_3_2_141_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690379"},{"key":"e_1_3_2_142_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-003-0482-2"},{"key":"e_1_3_2_143_1","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.0980"},{"key":"e_1_3_2_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.07.037"},{"key":"e_1_3_2_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(98)00327-9"},{"key":"e_1_3_2_146_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-2632-3"},{"key":"e_1_3_2_147_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.1697"},{"key":"e_1_3_2_148_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature04225"},{"key":"e_1_3_2_149_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0149"},{"key":"e_1_3_2_150_1","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e318226b376"},{"key":"e_1_3_2_151_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.15.8681"},{"key":"e_1_3_2_152_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2367"},{"key":"e_1_3_2_153_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1734"},{"key":"e_1_3_2_154_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2003.tb05975.x"},{"key":"e_1_3_2_155_1","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2013.96"},{"key":"e_1_3_2_156_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22289"},{"key":"e_1_3_2_157_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.11.047"},{"key":"e_1_3_2_158_1","doi-asserted-by":"publisher","DOI":"10.2174\/13816128113199990527"},{"key":"e_1_3_2_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.03.045"},{"key":"e_1_3_2_160_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-014-1580-9"},{"key":"e_1_3_2_161_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.882.13.5"},{"key":"e_1_3_2_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.01.552"},{"key":"e_1_3_2_163_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0863"},{"key":"e_1_3_2_164_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28843"},{"key":"e_1_3_2_165_1","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2016.1252891"},{"key":"e_1_3_2_166_1","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31821e05e8"},{"issue":"1","key":"e_1_3_2_167_1","first-page":"41","article-title":"Relationship of aberrant DNA hypermethylation of CHFR with sensitivity to taxanes in endometrial cancer","volume":"17","author":"Yanokura M","year":"2007","unstructured":"Yanokura M , BannoK , KawaguchiMet al. Relationship of aberrant DNA hypermethylation of CHFR with sensitivity to taxanes in endometrial cancer . Oncol. Rep.17 ( 1 ), 41 \u2013 48 ( 2007 ).","journal-title":"Oncol. Rep."},{"key":"e_1_3_2_168_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-0930"},{"key":"e_1_3_2_169_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2016.1118053"},{"key":"e_1_3_2_170_1","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2744(200010)29:2<59::AID-MC2>3.0.CO;2-6"},{"key":"e_1_3_2_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2010.02.006"},{"issue":"12","key":"e_1_3_2_172_1","first-page":"3101","article-title":"Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer","volume":"63","author":"Sasaki M","year":"2003","unstructured":"Sasaki M , KaneuchiM , SakuragiN , DahiyaR . Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer . Cancer Res.63 ( 12 ), 3101 \u2013 3106 ( 2003 ).","journal-title":"Cancer Res."},{"key":"e_1_3_2_173_1","doi-asserted-by":"publisher","DOI":"10.1002\/mc.20198"},{"key":"e_1_3_2_174_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067458"},{"key":"e_1_3_2_175_1","doi-asserted-by":"publisher","DOI":"10.31768\/2312-8852.2015.37(4):246-249"},{"key":"e_1_3_2_176_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2013-0162"},{"key":"e_1_3_2_177_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-10-0763"},{"key":"e_1_3_2_178_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-1578(10)60003-7"},{"key":"e_1_3_2_179_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2828"},{"key":"e_1_3_2_180_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24217"},{"key":"e_1_3_2_181_1","doi-asserted-by":"publisher","DOI":"10.3109\/01443615.2013.776027"},{"key":"e_1_3_2_182_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2015.08.010"},{"key":"e_1_3_2_183_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-156"},{"key":"e_1_3_2_184_1","doi-asserted-by":"publisher","DOI":"10.1159\/000218032"},{"key":"e_1_3_2_185_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2687"},{"key":"e_1_3_2_186_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.05.036"},{"key":"e_1_3_2_187_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1756"},{"key":"e_1_3_2_188_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-07-0511"},{"key":"e_1_3_2_189_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2004.06.044"},{"key":"e_1_3_2_190_1","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700060"},{"key":"e_1_3_2_191_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.05.004"},{"issue":"1","key":"e_1_3_2_192_1","first-page":"180","article-title":"Frequent SOCS3 and 3OST2 promoter methylation and their epigenetic regulation in endometrial carcinoma","volume":"5","author":"Chen H","year":"2015","unstructured":"Chen H , ZhangC , ShengYet al. Frequent SOCS3 and 3OST2 promoter methylation and their epigenetic regulation in endometrial carcinoma . Am. J. Cancer Res.5 ( 1 ), 180 \u2013 190 ( 2015 ).","journal-title":"Am. J. Cancer Res."},{"key":"e_1_3_2_193_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/682504"},{"key":"e_1_3_2_194_1","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12361"},{"key":"e_1_3_2_195_1","doi-asserted-by":"publisher","DOI":"10.1111\/his.12047"},{"key":"e_1_3_2_196_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800240"},{"key":"e_1_3_2_197_1","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.231.193"},{"key":"e_1_3_2_198_1","doi-asserted-by":"publisher","DOI":"10.4161\/epi.26701"},{"key":"e_1_3_2_199_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/946268"},{"key":"e_1_3_2_200_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800940"},{"key":"e_1_3_2_201_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2005.01900.x"}],"container-title":["Epigenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/epi-2016-0166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T21:03:41Z","timestamp":1715979821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/epi-2016-0166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":199,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.2217\/epi-2016-0166"],"URL":"https:\/\/doi.org\/10.2217\/epi-2016-0166","relation":{},"ISSN":["1750-1911","1750-192X"],"issn-type":[{"value":"1750-1911","type":"print"},{"value":"1750-192X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iepi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iepi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-11-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-05-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}